nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary Prevention
|
Marquis-Gravel, Guillaume |
|
|
40 |
8S |
p. S35-S42 |
artikel |
2 |
Disclaimer Page
|
|
|
|
40 |
8S |
p. A1 |
artikel |
3 |
Dyslipidemia and the Current State of Cardiovascular Disease: Epidemiology, Risk Factors, and Effect of Lipid Lowering
|
Brunham, Liam R. |
|
|
40 |
8S |
p. S4-S12 |
artikel |
4 |
Editorial Board
|
|
|
|
40 |
8S |
p. A2-A3 |
artikel |
5 |
Guideline-Directed Medical Therapy—Secondary Prevention Checklist
|
Bell, Alan |
|
|
40 |
8S |
p. S53-S56 |
artikel |
6 |
Information for Readers
|
|
|
|
40 |
8S |
p. A6 |
artikel |
7 |
Medications for Lipid Control: Statins vs Newer Drugs
|
McPherson, Ruth |
|
|
40 |
8S |
p. S26-S34 |
artikel |
8 |
Table of Contents
|
|
|
|
40 |
8S |
p. A4-A5 |
artikel |
9 |
The Challenges of Contemporary Atherosclerotic Cardiovascular Disease Management
|
Abramson, Beth L. |
|
|
40 |
8S |
p. S1-S3 |
artikel |
10 |
The Continuing Scourge of Atherosclerotic Cardiovascular Disease: Importance of Multidisciplinary and Innovative Person-Centred Approaches
|
Cheng, Alice |
|
|
40 |
8S |
p. S43-S52 |
artikel |
11 |
Traditional and Novel Markers: Target of Treatment vs Marker of Risk
|
Mancini, G. B. John |
|
|
40 |
8S |
p. S20-S25 |
artikel |
12 |
What Guidelines Say About Risk Reduction: Major Data on the Link Between Lipid Lowering and Outcomes
|
Thanassoulis, George |
|
|
40 |
8S |
p. S13-S19 |
artikel |